{"timestamp": 1771600227.088291, "value": {"ticker": "QNCX", "company_name": "Quince Therapeutics, Inc.", "short_name": "Quince Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 8897901, "float_shares": 49760877, "shares_outstanding": 55681490, "short_ratio": 0.51, "short_percent_of_float": 0.0376, "shares_short": 1875868, "shares_short_prior": 2617907, "insider_percent_held": 0.09332, "institution_percent_held": 0.39783, "total_cash": 26288000, "total_debt": 17993000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 1699.056, "current_ratio": 1.121, "book_value": 0.019, "price_to_book": 8.410526, "operating_cashflow": -38496000, "free_cashflow": -17977500, "price": 0.1598, "52w_high": 4.55, "52w_low": 0.125, "avg_volume": 49533990, "avg_volume_10d": 286328560, "full_time_employees": 36, "audit_risk": 7, "overall_risk": 7}}